Načítá se...
Using Molecular Markers to Guide Therapy of Metastatic Colorectal Cancer
Colorectal cancer remains one of the most commonly diagnosed cancers with almost one-fourth of patients presenting with metastatic disease at the time of diagnosis. As the repertoire of anticancer agents has expanded to treat colorectal patients with metastatic disease, life expectancies have increa...
Uloženo v:
| Vydáno v: | J Oncopathol |
|---|---|
| Hlavní autoři: | , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
2013
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4667749/ https://ncbi.nlm.nih.gov/pubmed/26640695 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.13032/tjop.2052-5931.100056 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|